Insert Article
Related articles
|
 |
 |
|
Webmasters: Add your website here:
Readers: Edit |
Discuss Listings
GenPhar
Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.
http://www.genphar.com/
Pharmos Corporation
Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
http://www.pharmoscorp.com/
Nephros Therapeutics, Inc.
Specialist in the design, development, and marketing of human cell replacement therapy systems, targeting inflammatory disease. Includes directions to research labs at Ann Arbor, Michigan, and corporate offices in Lincoln, Rhode Island.
http://www.nephrostherapeutics.com/
AplaGen Biopharmaceuticals
Development of cytokine analogs for cancer therapy, peptides for contraception, diagnosis and treatment of infertility. Includes introduction to technology, projects, key staff, and contacts for careers in Baesweiler, Germany.
http://www.aplagen.com/
Anhui Anke Biotechnology Co., Ltd.
Specializes in developing and manufacturing genetically engineered drugs; somatropin, interferon, including monoclonal affinity columns for recombinant subtypes, kits for fertility and sperm detection, in Hefei, China.
http://www.ankebio.com/
Expresson Biosystems Ltd.
Offers design of antisense design, target validation, consultancy, experimental services. Includes product information, overview of applications and company in Midlothian, Scotland.
http://www.expresson.com/
The Serono Group
A Swiss biotech company currently specializing in multiple sclerosis, fertility, growth therapies and AIDS wasting. Includes company history and milestones.
http://www.serono.com/
Hemobiotech Inc.
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas, United States.
http://www.hemobiotech.com/
Intra-Cellular Therapies, Inc.
Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts in New York, United States.
http://www.intracellulartherapies.com/
Gene Products, LLC.
Company offering gene synthesis, site-specific mutagenesis, expression optimization, prospective drug target validation services. Based in Dallas, Texas.
http://www.gene-products.com/
Aventis Pasteur
Researcher, developer, manufacturer and supplier of vaccines for use in humans. Includes company biography and product list, links to contacts and sites worldwide.
http://www.aventispasteur.com/
Biogen Inc.
Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts.
http://www.biogen.com/
Biophage Pharma
Company focusing on the development and commercialization of agents to prevent and control antibiotic resistant infections and inflammatory diseases. Includes explanation of modalities, services offered for microbial and tumor testing, details for investors and careers in Montreal, Canada.
http://www.biophage.com/
Rib-X Pharmaceuticals Inc.
Structure-based drug design start-up, specialising in the ribosome as a target, and bacterial antibiotic resistance. Includes mechanisms of action, glossary, careers, corporate news and contacts and directions in New Haven, Connecticut.
http://www.rib-x.com/
Protalex, Inc.
Drug development company, focusing on bioregulation of rheumatoid arthritis. Introduction to product, SEC filings, newsletters and contacts in Albuquerque, New Mexico.
http://www.protalex.com/
Affinium Pharmaceuticals
Developer of a novel class of antibiotics, under licence to major manufacturers. Including marketing profile, news archive and contacts in Toronto, Canada.
http://www.integrativeproteomics.com/
BioSphings AG
Innovating viral phospholipase inhibitor to prevent expression of Herpes specific genes, and intracellular viral antigens, and drug inducing death of tumor cells and autoreactive immune cells, in multiple sclerosis, rheumatism, and Crohns disease. Based in Leverkusen, Germany.
http://www.biosphings.com/
Biopro Pharmaceutical Inc.
Research and marketing, with focus on cancer and aging products for Asia, with offices in Mill Valley, California and Taipei, Taiwan.
http://www.biopropharm.com/
Chaperone Technologies
Offer novel peptide-based molecules to treat currently life-threatening infectious diseases, using technology for design of antibacterial, antifungal, and antiparasitic drugs, bio-pesticides and delivery enhancers for pharmaceuticals. Corporate office in Wayne, Pennsylvania.
http://www.chaperonetechnologies.com/
Dynamikos Corporation
Research and development in neurodegenerative disease, non-pesticide insect control, GSH receptor in Vancouver, Canada.
http://www.dynamikoscorp.com/
AusAm Biotechnologies, Inc.
Developing diagnostics and drugs from core discoveries in protein and polysaccharide chemistry, including anti-viral attachment inhibitors. Includes research oveerview, distributors, and offices in Chicago and Santa Monica, California.
http://www.ausambiotech.com/
Novacta Biosystems Ltd.
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Norwich, England.
http://www.novactabio.com/
ZymoGenetics, Inc.
Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.
http://www.zymogenetics.com/
Euroscreen
Drug discovery company focused on custom screening, luminescence testing and functional screening, interacting with G protein-coupled receptors. Offers custom cloning and production in Gosselies, Belgium.
http://www.euroscreen-discovery.com/
Pharming
Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.
http://www.pharming.com/
Xenova Group plc
Holding company with subsidiaries which discover and develop small molecule drugs derived from naturally occurring micro-organisms such as fungi and bacteria, primarily for the treatment of cancer. (Nasdaq: XNVA).
http://www.xenova.co.uk/
Vertex Pharmaceuticals Incorporated
Discovers, develops and sells novel, small molecule pharmaceuticals for treatment of diseases, such as HIV infection and AIDS, Cancer, Hepatitis C and Diabetic Neuropathy, which have limited or no effective treatments. (Nasdaq: VRTX).
http://www.vpharm.com/
Versicor, Inc.
Biopharmaceutical company focused on the marketing, development and discovery of pharmaceutical products for the treatment of bacterial and fungal infections. (Nasdaq: VERS).
http://www.versicor.com/
Aphios Corp.
Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product pipeline and profile of company in Woburn, Massachusetts.
http://www.aphios.com/
Octagen Corp.
Privately held company developing therapies for hemophilia and other genetic disorders, using recombinant Factor VIII and gene therapy. Includes clinical trial status, licensing, corporate profile and contacts in Bala Cynwyd, Pennsylvania.
http://www.octagen.com/
Shantha Biotechnics Pvt. Ltd.
Offering rDNA derived streptokinase, human inteferon alpha of type 2b, and hepatitis-B vaccine, with developments in endocrine, growth factors, immunotherapy, vaccine and diagnostics. Based in Hyderabad, India.
http://www.shanthabiotech.com/
Spring Bank Technologies, Inc.
Development of novel anti-viral therapies, including hepatitis B in Milford, Massachusetts.
http://www.springbanktech.com/
Endocube
Engaged in the identification, validation and selection of novel drugable targets and product candidates for the diagnosis and treatment of chronic inflammatory diseases. Profiles of technology, product pipeline and corporation in Labege, France.
http://www.endocube.fr/
Dongbao Enterprise Group Co., Ltd.
Conglomerate industrial group, with more than 20 subsidiaries, engaged in the field of pharmaceutical production and manufacturers of recombinants, especially human insulin in Shanghai, China.
http://www.dongbao.com/en/access/index.htm
BioMep Inc.
Company founded in 1997 to develop new therapies for bone diseases. Outlines products under development and news from Montreal, Canada.
http://www.biomep.com/
De Novo Pharmaceuticals Ltd
A Cambridge, UK based drug design company.
http://www.denovopharma.com/
Oxxon Therapeutics
Developing a portfolio of immunotherapeutics for infectious diseases and cancer using its proprietary boosting regime. Includes overview of technology, publications and corporate profile, with contacts in Oxford, England and Boston, Massachusetts.
http://www.oxti.com/
Archemix
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
http://www.archemix.com/
BioRexis Pharmaceutical Corp.
Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therpeutic applications, and yeast host cell expression systems for production. Opportunities and contacts in King of Prussia, Pennsylvania.
http://www.biorexis.com/
ImmunoGen, Inc.
Called Tumor-Activated Prodrugs (TAPs), Products are small molecule anticancer agents with high potency and reduced toxicity.
http://www.immunogen.com/
Cue Biotech Inc.
Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with media resources, list of publications, and opportunities in Chicago, Illinois.
http://www.cuebiotech.com/
ConjuChem, Inc.
Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview, research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada.
http://www.conjuchem.com/
Connetics Corporation
Principally engaged in rapid commercialization of new therapies in the areas of rheumatology and dermatology. Includes product pipeline, investor relations, recruitment and contacts in Palo Alto, California.
http://www.connetics.com/
Genentech, Inc.
Company works in the discovery, development, production, and marketing of human biopharmaceuticals.
http://www.genentech.com/
Generex Biotechnology
Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
http://www.generex.com/
Genfit
Focused on gene regulation and drug discovery strategies. Develops new drugs addressing diseases, such as arteriosclerosis, obesity, diabetes, inflammatory diseases. Based in Europe.
http://www.genfit.com/
GlycoTech Corporation
Research glycobiology company developing diagnostics and therapeutics for cancer and inflammatory diseases based on the interaction of glycoconjugates and their receptors.
http://www.glycotech.com
Lybradyn: Microbial Natural Products
Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation of the procedures used in collecting the data.
http://www.lybradyn.com/
Millennium Pharmaceuticals, Inc.
Uses genomics to develop therapeutic drugs.
http://www.mlnm.com/
Morphochem
Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
http://www.morphochem.de/
Modular Genetics, Inc.
Supporting basic research, drug design, drug screening and chemical synthesis.
http://www.modulargenetics.com/
Myogen, Inc.
Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product pipeline, research overview, careers, contacts and directions in Westminster, Colorado.
http://www.myogen.com/
DNAvaccine.com
Resouorce for articles, frequently asked questions, tools, literature, resources, and online services. Maintained by Aldevron LLC, Fargo, North Dakota.
http://dnavaccine.com/
Texas Biotechnology Corporation
Dedicated to the discovery, design, and development of new pharmaceutical compounds to treat vascular disease.
http://www.tbc.com/
Vical, Inc. (VICL)
Developing gene-based treatments for cancer and infectious disease vaccines. Uses naked DNA technology and proprietary lipids to deliver genes into cells in the body.
http://www.vical.com/
Virax Holdings, Ltd.
Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. Based in Australia.
http://www.virax.com.au/
XOMA
Development and manufacturing of recombinant proteins and peptides, primarily those derived from the host-defense protein BPI, for manufacturing biopharmaceuticals.
http://www.xoma.com/
Pharma 21
Doing research and development for products in the treatment of brain and spinal cord damage. Lists current projects and how the drugs supposed to work.
http://www.pharma21.net/
Sierra Sciences
Developing drugs and therapies to reverse the effects of human aging by focusing on preserving the length of telomeres, or the ends of DNA, to keep them more resiliant.
http://www.sierrasci.com/
Mixture Sciences, Inc.
A privately held company that specializes in research for treatment of HIV/AIDS, cancer, diabetes, multiple sclerosis, and infectious diseases, including Lyme Disease. Lists research projects and procedures.
http://www.mixturesciences.com/
BresaGen, Ltd.
Focused on the discovery and commercialization in the fields of reproduction and development, applying gene technologies to human and veterinary biotherapeutics. Ordering information for embryonic stem cells, manufacture of recombinant proteins, such as equine somatotropin, in Thebarton, South Australia.
http://www.bresagen.com.au/
Replidyne
In the process of creating bacteria that will block infectious disease DNA replication. Includes information about the company, news releases and research goals.
http://www.replidyne.com/
|
